(Q34986144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

A comprehensive model for the humoral coagulation network in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

T Wajima

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

G K Isbister

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

10 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

290-298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516255%20AND%20SRC:MED&resulttype=core&format=json

Theories of blood coagulation

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Pharmacogenetics of warfarin: current status and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

A model for venom-induced consumptive coagulopathy in snake bite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

The dynamics of thrombin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

A mathematical model of the kinetics of blood coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II. Results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Platelets and thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

The kinetic model and simulation of blood coagulation--the kinetic influence of activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

A kinetic model for simulation of blood coagulation and inhibition in the intrinsic path.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Mathematical modeling and computer simulation in blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Mathematical model for the blood coagulation prothrombin time test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Analysis of the activated partial thromboplastin time test using mathematical modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Tissue factor pathway inhibitor: structure, biology and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Development of a dosing strategy for enoxaparin in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Comprehensive clinical and statistical analysis of hemophilia in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Characteristics of indirect pharmacodynamic models and applications to clinical drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Cyclic interconversion of vitamin K1 and vitamin K1 2,3-epoxide in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

Heparin and low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

Effect of heparin on the inhibition of the contact system enzymes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

Biochemistry and Physiology of Blood Coagulation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

Plasma concentrations of dihydro-vitamin K1 following dietary intake of a hydrogenated vitamin K1-rich vegetable oil

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

Assessment of vitamin K status in human subjects administered "minidose" warfarin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

Models of blood coagulation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021

Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newborn

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.87

7 January 2021